The Fixed Combination of Pioglitazone and Metformin Improves Biomarkers of Platelet Function and Chronic Inflammation in Type 2 Diabetes Patients: Results from the PIOfix Study

BACKGROUND: Type 2 diabetes mellitus (T2DM) is characterized by a proinflammatory and procoagulant condition. This study investigates the impact of a pioglitazone plus metformin therapy on biomarkers of inflammation and platelet activation in comparison to a treatment with glimepiride plus metformin...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Schöndorf, Thomas, Musholt, Petra B, Hohberg, Cloth, Forst, Thomas, Lehmann, Ute, Fuchs, Winfried, Löbig, Mirjam, Müller, Jürgen, Pfützner, Andreas
Format: Artigo
Sprache:Inglês
Veröffentlicht: Diabetes Technology Society 2011
Schlagworte:
Original Articles
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3125938/
https://ncbi.nlm.nih.gov/pubmed/21527115
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge